1Lakhani SR. The transition from hyperplasia to invasive carcinoma of the breast[J] .J pathol, 1999,187(3) :272.
2Abdel - Fatah TM. High frequency of coexistence of columnar cell lesions, lobular carcinoma and invasive lobular carcinoma[J ]. Am J Surg Pathol, 2006, 30(6) : 665.
3Lewis JT. An analysis of breast cancer risk in women with single, multiple, and atypical papilloma[J]. Am J Surg Pathol, 2006, 30 (6):665.
5Rohayem J, Diestel koetter P, Weigle B, et al. Antibody re-Sponse to the tumor associate dinhibitor of a pop to sisprotein Survivin in cancer patients[J]. Cancer Res, 2000, 60(7) : 1815 - 1817.
6Nasu S, Yagihashi A, Izawa A, et al. Survivin mRNA expression in patients with breast cancer[J]. Anticancer Res, 2002, 22(3) : 1839 - 1843.
7Choi KS, Lee TH, Jung MH. Ribozyme-mediated cleavage of the human survivin mRNA and inhibition of antiapoptotic function of survivin in MCF- 7 cells[J]. Cancer Gene Ther, 2003, 10(2) :87 -95.
10Ikehara M, Oshita F, Ito H, et al. Expression of cyclin D1 but no of cyclin D1 Eisan indicator of poor prognosis in small adenocarcinoma of the lung[J]. Oncol Rep, 2003,10(1) :137 - 139.
4Sasaki T, Lopes MB, Hankins GR, et al. Expression of Survivin, an inhibitor of apoptosis protein, in tumors of the nervous system. Acta Neuropathol (Berl), 2002,104(1):105-109
5Falleni M, Pellegrini C, Marchetti A, et al. Survivin gene expression in early-stage non-small cell lung cancer. J Pathol, 2003, 200(5):620-626
6Tanaka K, Iwamoto S, Gon G, et al. Expression of Survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res, 2000,6(1): 127-134
7Kennedy SM, O'Driscoll L, Purcell R, et al. Prognostic importance of Survivin in breast cancer. Br J Cancer, 2003,88(7): 1077-1083
8Rodriguez JA, Span SW, Ferreira CG, et al. CRM1-mediated nuclear export determines the cytoplasmic localization of the antiapoptotic protein Survivin. Exp Cell Res, 2002,275(1): 44-53
9Mesri M, Morales-Ruiz M, Ackermann EJ, et al. Suppression of vascular endothelial growth factor-mediated endothelial cell protection by Survivin targeting. Am J Pathol, 2001,158(5): 1757-1765
10Blanc-Brude OP, Mesri M, Wall NR, et al. Therapeutic targeting of the Survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis. Clin Cancer Res, 2003,9(7): 2683-2692
